The verified answer
As of Aug 2026, DEPLOY verifies Hocoma: 1 model, 1 deployment across 1 region, 1 active incident. 4 sources back the record.
CategoryExoskeletons
Overview
Hocoma is a Swiss medical robotics company and global market leader in robotic and sensor-based rehabilitation devices, developing the Lokomat gait therapy system, Armeo upper limb rehabilitation devices, and Erigo early mobilization system. Founded in 1996 in Volketswil near Zurich by Dr. Gery Colombo, Matthias Jörg, and Peter Hostettler, the company merged with Hong Kong-based DIH International in 2016 and became a wholly-owned subsidiary of DIH Nevada as of July 2021. Its devices are deployed in clinics and hospitals worldwide for neurological rehabilitation of stroke, spinal cord injury, and other movement disorders.
Verified record
- Verified deployments
- 1 deployment on file
- Active incidents
- 1 incident on file
Key facts
CEO
Founders
Parent
Subsidiaries
Employees
Revenue (2014)
Products
Financial stage
Data & sources
Web sources
4
4 sources backing this record.View all →
Models (1)
View all models →Partnerships
Every company Hocoma has built with, alongside the ones only announced in a press release.
Hocoma on the deployment map
View the global map1 verified deployment across 1 region, newest verified Jun 2024. Explore where Hocoma's robots are operating, by place and type.
View the full Hocoma deployment record →
Relationships
Current leadership (3)
- Dr. Gery Colombo CEO & Co-founderSEC-verified
- Peter Hostettler Co-founder & Chairman of the BoardSEC-verified
- Mike Fuhrmann Chief Creative OfficerSEC-verified
Founders (3)
- Dr. Gery Colombono longer at company
- Matthias Jörgno longer at company
- Peter Hostettlerno longer at company
Former / Previously (1)
- Matthias Jörg Co-founderSEC-verified
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Hocoma (1)
- FDA Class 2 recall of Hocoma Lokomat System due to software sensitivity bug2009-05-27 · Recall
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Hocoma1 deployment
Recent coverage
Hocoma in third-party press
Peers
26 peers across 1 segment. Every Hocoma competitor derived from shared form-factor and application-domain edges.
exoskeleton(26)
23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%
- ATOUNdirect competitor(inferred)moderate
- Againer Skidirect competitor(inferred)moderate
- B-TEMIAdirect competitor(inferred)moderate
- Bionik Laboratoriesdirect competitor(inferred)moderate
- Cyberdynedirect competitor(inferred)moderate
- Daiya Industry Co., Ltd.direct competitor(inferred)moderate
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 2 operating
Every company Hocoma has built with, alongside the ones only announced in a press release.
All 2 partnerships
open in the atlas →- hocoma x awswithAWS976technology—operating
- hocoma x nvidiawithNVIDIA1108technology—operating
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 11, 2026
Hocoma - Lokomat
- Record createdJun 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
Hocoma Lokomat at Global
- Incident recordedMay 27, 2009
FDA Class 2 recall of Hocoma Lokomat System due to software sensitivity bug
Sources (4)
- https://www.hocoma.com/us/media-releases/together-into-the-future-hocoma-merges-with-dih-international-to-provide-total-solution-for-modern-rehabilitation/
- https://exoskeletonreport.com/product/lokomat/
- Hocoma - Crunchbase Company Profile · https://www.crunchbase.com/organization/hocoma
- Mike Fuhrmann Appointed to Hocoma Executive Board · https://www.hocoma.com/us/media-releases/mike-fuhrmann-appointed-to-hocoma-executive-board/
Common questions
What is Hocoma?
What does Hocoma make?
Is Hocoma publicly traded?
Who competes with Hocoma?
Who is the CEO of Hocoma?
How can I invest in Hocoma?
Where is Hocoma headquartered?
Who owns Hocoma?
Where does Hocoma operate robots?
How many robots has Hocoma deployed?
Is Hocoma a top robotics company?
When was Hocoma founded?
Are there any incidents involving Hocoma?
Is Hocoma safe?
Methodology: Verified · 4 sources (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 4
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Hocoma.Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Ascentiz2 models
- DIH Medical2 models
- Ekso Bionics2 models
In the press
Recent coverage mentioning Hocoma from third-party publications. Automatically surfaced; not part of the verified registry record.
Effect of Lokomat Robotic Rehabilitation on Balance - PMC study
A 2025 peer-reviewed study in PMC confirmed the effectiveness of the Lokomat system (Hocoma AG, Switzerland) for robotic rehabilitation programs aimed at improving gait and…
Lokomat - Robotic gait training solution
Hocoma's Lokomat system provides highly intensive gait rehabilitation using robot-assisted training to increase muscle strength and range of motion for neurological patients.
Hocoma merges with DIH International
Swiss medtech company Hocoma merged with Hong Kong-based DIH International, combining complementary core competencies in robotic rehabilitation solutions.
Mike Fuhrmann Appointed to Hocoma Executive Board
Hocoma added Mike Fuhrmann as Chief Creative Officer to its executive board, focusing on global branding and positioning as innovative market leader of functional movement therapy.
Class 2 Device Recall LokomatSystem
FDA Class 2 recall of Hocoma Lokomat System with Pediatric Module due to software sensitivity value changes leading to higher force and trajectory deviation limits. 7 units…
Machine-readable surfaces
- Markdown mirror: /companies/hocoma.md
- RSS feed: /companies/hocoma/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/00b9f022-6316-4c34-b8b2-19e8ee93b84b
- Revision history: /companies/hocoma/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Ascentiz2 models
- DIH Medical2 models
- Ekso Bionics2 models
Video
The Lokomat® by Hocoma The Lokomat® is the world leading robotic rehabilitation device that offers highly intensive, physiologic training. The Lokomat® improves the therapy outcome by providing highly intensive, individu
C-Mill is used for physical therapy interventions in the form of treadmill training that simulates challenges in everyday life through augmented and virtual rea
The Hocoma Andago was demonstrated at MINT 2018 by a patient at Hobbs Rehab who has Guillain-Barré syndrome (GBS). The Andago is the world’s first free-moving
The ArmeoPower by Hocoma is a highly advanced arm and hand rehabilitation device for early-stage patients, even before they develop active movement. It is the
Hocoma is the leader in robotic rehabilitation therapy for neurological movement disorders. We are a globally active medical technology company based near Zuric
Lokomat - highly intensive physiological gait rehabilitation for severely impaired neurological patients. ''I've heard that if we expect the effect of the ther
The Lokomat is the world's leading robotic medical device that provides highly repetitive and the most physiological gait training - especially to severely impa
The Hocoma ManovoSpring is an instrumented hand orthosis which can be used in combination with the ArmeoSpring for patients who are focusing on hand rehabilitat
The Armeo Power is an advanced robotic motorized arm orthosis that supports the weight of a person’s arm and is designed to contribute to arm rehabilitation. It
The only Therapy solution that uniquely combines gradual verticailization, Leg Mobilization, Intensive sensorimotor stimulation along with cyclic leg loading.
WATCH THE WHOLE SESSION ON https://www.hocoma.com/landing-page/webinar-the-integration-of-robotic-devices-in-the-acute-phase/ Robotics combined with standard
The Armeo Spring is an exoskeleton device for arm and hand rehabilitation that is spring-loaded to provide support during interactive computer games. The Arm
Advance Mobile Robotic System with sensor based technology, helping the patient with Neuro Muscular deficit , Orthopaedic, Paediatric and Geriatric problems.
Reality vs attention
Hocoma draws attention at the 25th percentile but verifies reality at the 17th percentile among exoskeletons. Hype Gap +7.8, 22nd widest among exoskeletons.
6-month trend
Analysis
Safety profile within acceptable range for category. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 29, 2026